The rates and measurement of adherence to acamprosate in randomised controlled clinical trials: A systematic review.

Kim DonoghueLaura HermannEileen BrobbinColin Drummond

Published in: PloS one (2022)

Adherence to acamprosate in clinical trials can be poor with low confidence in the methods used to measure it. Adherence rates therefore might not be accurate, which has implications for determining the efficacy of acamprosate.

Keyphrases

clinical trial
glycemic control
study protocol
phase ii
high resolution
type diabetes
metabolic syndrome
adipose tissue
phase iii
insulin resistance